| During the past two decades, rapid development of nanomedicine has offered new opportunities in designing and evaluating novel treatment strategies for several neurological and psychiatric diseases. Application of nanomaterials as drug carriers in psychiatry has potentially numerous advantages, primarily in terms of the increased therapeutic efficiency of the medicament, and reduction of toxicity. Several research efforts have already been focused on the synthesis of antipsychotic and antidepressant nano-based drug delivery systems. Many of these nanoparticle systems have been successfully tested both in in vitro conditions and on animal experimental models. This short review presents and discusses recent discoveries in the emerging field of nanopsychiatry. |
full paper (pdf, 64 Kb)